News
Imec showcases ingestible sensor for gut studies
Nanoelectronics specialist Imec will demonstrate a miniaturised, …
20869 items found
News
UK's long-term R&D investment policy welcomed
The decision by the UK government to set new 10-year budgets for …
News
Pfizer snaps up PD-1/VEGF drug from China's 3SBio
Pfizer has joined the ranks of companies developing cancer drugs that …
News
Regeneron swoops on genetic testing firm 23andMe
DNA testing company 23andMe looks destined to be taken over by a …
Market Access
EAPs: Market access outside of the US and Western Europe
Early access programmes (EAPs) for novel medicines are an …
R&D
Tariff turbulence: Navigating US trade shifts in the medtech supply chain
The US has been at the centre of a shift in global trade dynamics …
News
Japan follows UK in GSK's comeback tour for Blenrep
The revitalisation of GSK's blood cancer therapy Blenrep has …
News
Partner of ex-Theranos CEO raising cash for testing start-up
The partner of former Theranos founder and chief executive Elizabeth …
News
BioMarin starts rebuilding after its downsizing spree
BioMarin has been resetting its business with cuts in headcount and a …
News
FDA finally okays Novavax's COVID-19 jab, with restrictions
The FDA has granted full approval to Novavax's COVID-19 vaccine after …
News
FDA clears first blood test for Alzheimer's disease
The FDA has approved the first blood test for Alzheimer's disease …
R&D
Modelling biologics: Challenges and opportunities, with Dr Dhaval Shah
Advanced simulation and modelling is already making huge waves in how …
News
Imec showcases ingestible sensor for gut studies
Imec will demonstrate an ingestible sensor device today that can monitor gut health and could be a valuable tool for research and clinical trials.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
R&D
Modelling biologics: Challenges and opportunities, with Dr D...
From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
Patients
Partner Content
Operationalize: Expanded Access Programs comes to the West C...
Improving Global Access to Life-Changing Therapeutics...
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).